PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.
PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:
- Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
- Assessment of regulatory needs (ARN).
- Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.
A summary of all the substance-specific activities can be found under ‘Details’ for each entry.
Further information
- Understanding PACT
- Integrated Regulatory Strategy
- Substances of potential concern
- Dossier Evaluation status
- Substance evaluation
- Endocrine disruptor assessment
- PBT assessment
- Assessment of regulatory needs list
- Registry of CLH intentions until outcome
- Registry of SVHC intentions until outcome
- Recommendations for inclusion in the Authorisation list
- Registry of restriction intentions until outcome
Filter the list
The List does not contain any Substances.
| Data generation and assessment | ARN | Regulatory risk management | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (3Z)-hex-3-en-1-yl 2-methylprop-2-en-1-yl ether | 439-790-0 | 292605-05-1 | - | - | - | - | 1 | - | - | - | - | Details |
| (4-phenylbutyl)phosphinic acid | 420-450-5 | 86552-32-1 | - | - | - | - | 1 | - | - | - | - | Details |
| (4-tert-butyl-2,6-dimethylphenyl)acetonitrile | 284-183-4 | 84803-57-6 | - | - | - | - | 1 | - | - | - | - | Details |
| (4aR,5S,8R,8aS)-1,2,3,4,4a,5,8,8a-octahydro-1,4:5,8-dimethanonaphthalene | 700-678-4 | - | - | - | - | - | 1 | - | - | - | - | Details |
| (4E)-4-(C13-C17)alkylidene-3-(C12-C16)alkyloxetan-2-one | 939-401-9 | - | - | - | 3 | - | - | - | - | - | - | Details |
| (4E)-4-METHYL-5-(4-METHYLPHENYL)-4-PENTENAL | 700-748-4 | 1226911-69-8 | - | - | - | - | 1 | - | - | - | - | Details |
|
(4R)-4-methyl-1,3-dioxolan-2-one
(R)-1,2-PROPYLENE CARBONATE
|
437-320-9 | 16606-55-6 | - | - | - | - | 1 | - | - | - | - | Details |
| (4S)-1-methyl-4-(6-methylhepta-1,5-dien-2-yl)cyclohexene | 610-461-5 | 495-61-4 | - | - | 1 | - | - | - | - | - | - | Details |
| (4Z)-cyclopentadec-4-en-1-one | 630-473-4 | 14595-54-1 | - | - | - | - | 1 | - | - | - | - | Details |
| (4Z)-hept-4-en-2-yl salicylate | 700-488-1 | 873888-84-7 | - | - | 1 | - | 1 | - | - | - | - | Details |